Promising Silver-Based Anti-Cancer Drugs Discovered (VIDEO)
Caption
A family of economical silver-based complexes show very promising results against a number of human cancers in laboratory tests, with very low toxicity in rat studies and minimal effects on healthy cells. One of these, UJ3, is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human esophageal cancer, breast cancer and melanoma. Dr Zelinda Engelbrecht, from the University of Johannesburg, shows how UJ3 targets mitochondria inside cancer cells.
Credit
Dr Zelinda Engelbrecht, Ms Therese van Wyk at the University of Johannesburg.
Usage Restrictions
None
License
Licensed content